-
VX-661: F508del CFTR Corrector Workflow
2026-09-07
Build a reproducible VX-661 workflow that separates CFTR trafficking rescue from channel potentiation, with practical controls for epithelial, biochemical, and functional assays. The guide also translates new calnexin findings into variant-aware assay design and troubleshooting decisions.
-
GLT-1, CB1-CREB Signaling, and TBI Cognition
2026-09-05
A 2025 Biomolecules study identifies an astrocyte-centered mechanism linking endocannabinoid signaling to glutamate excitotoxicity, neuronal apoptosis, and cognitive dysfunction after traumatic brain injury. Using pharmacological manipulation, behavioral testing, and molecular assays, the authors show that restoring GLT-1 while inhibiting the CB1-CREB pathway is associated with improved neurological outcomes in mice.
-
PGF2α/PTGFR and HIF-1α in Endometrial Breakdown
2026-09-05
This 2024 study identifies PGF2α signaling through PTGFR, the FP receptor, as a major regulator of endometrial breakdown and vascular permeability in a mouse menstrual-like model. Its combination of pharmacological inhibition, molecular profiling, tissue localization, and HIF-1α promoter-binding analysis provides a mechanistic framework for studying how hypoxia-responsive signaling coordinates menstrual-like tissue remodeling.
-
Saquinavir and Membrane-First Assay Design
2026-09-04
Saquinavir is examined here as a mechanistic anchor for HIV protease inhibitor research and membrane-interaction studies. Learn how IAM-LC, OT-CEC-MS, and disciplined compound handling can distinguish target inhibition from permeability-related behavior without overstating translational evidence.
-
TRPV1+ Nerves and the Somato-Autonomic Reflex
2026-09-04
The reference study identifies a neural route by which stimulating TRPV1+ peripheral afferents at the nape suppresses systemic inflammation through coordinated brainstem, endocrine, sympathetic, and vagal signaling. Its combination of targeted sensory stimulation, genetic validation, hormone and cytokine measurements, and splenic RNA sequencing provides a mechanistic framework for studying neuroimmune regulation.
-
GSK-923295: Reading Mitotic Phenotypes
2026-09-03
GSK-923295 is a CENP-E inhibitor that creates a powerful framework for studying mitotic arrest and chromosome alignment. This article explains how to distinguish direct motor inhibition from centromere-architecture defects using complementary imaging and cell-cycle assays.
-
D-Luciferin sodium salt for CAR-M Imaging
2026-09-03
D-Luciferin sodium salt converts firefly luciferase expression into a practical, non-invasive readout for CAR-macrophage studies, from plate-based ATP-dependent assays to longitudinal oncology imaging. This guide connects substrate handling with mRNA-LNP CAR-M workflows and provides optimization checkpoints that help distinguish reporter biology from genuine changes in cell viability or tumor burden.
-
HyperScript First-Strand cDNA Synthesis Kit Workflow
2026-09-02
Convert challenging bacterial and mammalian RNA into dependable first-strand cDNA for PCR amplification and qPCR reaction workflows. The HyperScript™ First-Strand cDNA Synthesis Kit is especially useful when transcripts are scarce, structurally complex, or poorly suited to a single primer strategy.
-
(S)-(+)-Dimethindene maleate Workflow
2026-09-02
This guide explains how to use (S)-(+)-Dimethindene maleate as a dossier-defined M2 muscarinic receptor antagonist in receptor and functional pharmacology workflows, while accounting for its additional H1 histamine receptor antagonism. It is intended for controlled scientific research and should not be used for diagnosis, treatment, or clinical decision-making.
-
Alda 1 Workflows for ALDH2 Cardiac Research
2026-09-01
Alda 1 is a genotype-aware ALDH2 activator for connecting aldehyde handling with cardiomyocyte proliferation, pressure-overload heart failure, and cardiac ischemia research. This workflow-focused guide covers assay design, exploratory dosing, variant comparisons, and troubleshooting, while separating mechanistic evidence from translational hypotheses.
-
Palonosetron Hydrochloride: Receptor-to-Kidney Insight
2026-08-31
Palonosetron hydrochloride is more than a long-acting 5-HT3 receptor antagonist: it is a useful probe for connecting receptor pharmacology with renal organic-cation transport. This article translates receptor and OCT2/MATE1 assay evidence into practical decisions for cancer research and antiemetic studies.
-
THZ1 for Reliable CDK7 Cell Assays
2026-08-31
Learn how THZ1 (SKU A8882), a covalent CDK7 inhibitor, can improve the interpretation and reproducibility of cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide connects mechanism, solvent handling, concentration design, orthogonal apoptosis assays, and practical supplier evaluation for cancer biology and T-ALL research.
-
ER Stress, GRP78/ATF6/CHOP, and Intestinal Stem Cells
2026-08-30
The reference study identifies unresolved endoplasmic reticulum stress as a negative regulator of intestinal stem-cell abundance and differentiation in mice. Its central contribution is the mechanistic connection of GRP78/ATF6/CHOP activation and p44/42 MAPK suppression with crypt-cell apoptosis, reduced proliferation, and intestinal barrier injury.
-
Proteoform-Specific Drug Interactions in Native Membranes
2026-08-29
Lutomski and colleagues developed a native mass-spectrometry workflow that releases membrane proteins and signaling complexes directly from retina rod disc membranes, preserving links between proteoforms, lipid modifications, and binding partners. The study shows how this approach can distinguish off-target interactions of sildenafil and vardenafil with PDE6 and reveal modification-dependent assembly of G-protein complexes.
-
LGK-974 Workflow for Wnt-Driven Cancer Studies
2026-08-29
Build reproducible PORCN inhibition workflows for Wnt secretion, pathway-response, and pancreatic cancer assays with LGK-974. The guide connects upstream Wnt ligand control to the CDK4/6–BET findings reported in PDAC and highlights practical dosing, controls, and troubleshooting.